Reteplase in the treatment of peripheral arterial and venous occlusions: A pilot study

Journal of Vascular and Interventional Radiology

Volumn 11, Issue 7, 2000, Pages 849-854

  Ouriel, Kenneth ^a   Katzen, Barry ^b   Mewissen, Mark ^c   Flick, Pamela ^d   Clair, Daniel G ^a   Benenati, James ^b   McNamara, Thomas O ^e   Gibbens, Douglas ^f  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Miami Cardiovascular Institute (MCVI) Baptist Health South Florida   (United States)

^c Milwaukee Heart Institute   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Department of Medicine Rutgers Health Community Medical Center Internal Medicine Residency Program   (United States)

Author keywords

Reteplase; Thrombolysis; Tissue type plasminogen activator

Indexed keywords

HEPARIN; RETEPLASE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VEIN INSUFFICIENCY;

EID: 0033914720     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61799-0     Document Type: Article

References (15)

1. Anonymous. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220: 251-266.
2. Anonymous. A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators (see comments). N Engl J Med 1997; 337:1118-1123.
3. Gurbel PA, Serebruany VL, Shustov AR, et al. Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries. J Am Coll Cardiol 1998; 31:1466-1473.
4. Martin U. Clinical and preclinical profile of the novel recombinant plasmiogen activator retelplase. In: Sasahara AA, Loscalzo J, eds. New therapeutic agents in thrombosis and thrombolysis. New York: Marcel Dekker, 1997; 495-511.
5. Martin U, Sponer G, Strein K. Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitro. Blood Coagul Fibrinol 1993; 4:235-242.
6. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version [abstract]. J Vasc Surg 1998; 26:517-538.
7. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 1998; 338:1105-1111.
8. Ouriel K, Kandarpa K, Schuerr DM, Hultquist M, Hodkinson G, Wallin B. Prourokinase vs. urokinase for recanalization of peripheral occlusions, safety and efficacy: The PURPOSE Trial. JVIR 1999; 10:1083-1091.
9. McNamara TO, Fischer JR. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR 1985; 144:769-775.
10. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1999; 29:4-11.
11. Meierhenrich R, Carlsson J, Seifried E, et al. Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency. Int J Cardiol 1998; 65:57-63.
12. Meyerovitz M, Goldhaber SZ, Reagan K, et al. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology 1990; 175:75-78.
13. Davidian MM, Powell A, Benenati JF, Katzen BT, Becker GJ, Zemel G. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions. JVIR 2000; 11: 289-294.
14. Semba CP, Murphy TP, Bakal CW, Calis KA, Matalon TAS. Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. JVIR 2000; 11:149-161.
15. Semba CP, Bakal CW, Calis KA, et al. Alteplase as an alternative to urokinase. JVIR 2000; 11:279-287.